Literature DB >> 26727279

Abnormal Cholesterol Among Children and Adolescents in the United States, 2011-2014.

Duong Nguyen, Brian Kit, Margaret Carroll.   

Abstract

Cardiovascular disease (CVD) is a leading cause of death among adults in the United States. To improve the cardiovascular health of the U.S. population, clinical practice guidelines recommend screening children and adolescents for risk factors associated with CVD, including abnormal blood cholesterol levels. This report provides 2011-2014 estimates from the National Health and Nutrition Examination Survey (NHANES) on the prevalence of high total cholesterol, low high-density lipoprotein (HDL) cholesterol, and high non-HDL cholesterol among children and adolescents aged 6-19. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26727279

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  19 in total

Review 1.  Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms.

Authors:  Frank W Booth; Christian K Roberts; John P Thyfault; Gregory N Ruegsegger; Ryan G Toedebusch
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 2.  Prevention of Cardiovascular Diseases in Children and Adolescents.

Authors:  Simonetta Genovesi; Marco Giussani; Antonina Orlando; Maria Grazia Battaglino; Elisa Nava; Gianfranco Parati
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-04-30

3.  Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors.

Authors:  Sally Sultan; Michael Dowling; Adam Kirton; Gabrielle DeVeber; Alexandra Linds; Mitchell S V Elkind
Journal:  Pediatr Neurol       Date:  2017-10-10       Impact factor: 3.372

4.  Exercise and Cardiovascular Disease Risk Factors in Children and Adolescents With Obesity: A Systematic Review With Meta-Analysis of Randomized Controlled Trials.

Authors:  George A Kelley; Kristi S Kelley; Russell R Pate
Journal:  Am J Lifestyle Med       Date:  2021-02-19

5.  Navy Bean and Rice Bran Intake Alters the Plasma Metabolome of Children at Risk for Cardiovascular Disease.

Authors:  Katherine J Li; Erica C Borresen; NaNet Jenkins-Puccetti; Gary Luckasen; Elizabeth P Ryan
Journal:  Front Nutr       Date:  2018-01-19

6.  A Pilot Randomized Controlled Clinical Trial to Assess Tolerance and Efficacy of Navy Bean and Rice Bran Supplementation for Lowering Cholesterol in Children.

Authors:  Erica C Borresen; NaNet Jenkins-Puccetti; Katie Schmitz; Dustin G Brown; Austin Pollack; Amanda Fairbanks; Melissa Wdowik; Sangeeta Rao; Tracy L Nelson; Gary Luckasen; Elizabeth P Ryan
Journal:  Glob Pediatr Health       Date:  2017-02-16

7.  The influence of maternal body mass index and physical activity on select cardiovascular risk factors of preadolescent Hispanic children.

Authors:  Basil A Alhassan; Ying Liu; Deborah Slawson; Jonathan M Peterson; Jo-Ann Marrs; William A Clark; Arsham Alamian
Journal:  PeerJ       Date:  2018-12-13       Impact factor: 2.984

8.  The relationship between payer type and lipid outcomes in response to clinical lifestyle interventions in youth with dyslipidemia.

Authors:  Jacob C Hartz; Elizabeth Yellen; Annette Baker; Justin Zachariah; Heather Ryan; S Skylar Griggs; Nirav K Desai; Ravi Yanumula; Samuel Vinci; Caroline Brantley; Jennifer Bachman; Ellen McAuliffe; Kimberlee Gauvreau; Michael Mendelson; Sarah de Ferranti
Journal:  BMC Pediatr       Date:  2019-07-02       Impact factor: 2.125

Review 9.  The Liver in Children With Metabolic Syndrome.

Authors:  Ebe D'Adamo; Valeria Castorani; Valerio Nobili
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

10.  Dyslipidemia and Fatty Liver Disease in Overweight and Obese Children.

Authors:  Asma Deeb; Salima Attia; Samia Mahmoud; Ghada Elhaj; Abubaker Elfatih
Journal:  J Obes       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.